Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-20-030109

Director disposed of 518,519 shares (other)

  • Director acquired 124,158 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2020-10-29 Other disposition −410,405 1,336,088 I
Bolzon Bradley J PhD Director 2020-10-29 Other acquisition +105,681 105,681 I
Bolzon Bradley J PhD Director 2020-10-29 Other disposition −105,681 0 I
Bolzon Bradley J PhD Director 2020-10-29 Other disposition −2,433 7,922 I
Bolzon Bradley J PhD Director 2020-10-29 Other acquisition +18,477 40,648 D
Loading xslF345X03/doc4.xml…